| Clinical characteristic | | Tfh | Breg | M (P25, P75) | | | M (P25, P75) | | |
| Age (year) | | | 111.0 | 0.163 | | 136.5 | 0.570 | ≤60 | 14 | 9.97 (7.08, 15.85) | | | 3.32 (1.02, 4.69) | | | >60 | 22 | 7.93 (4.77, 11.17) | | | 2.02 (1.14, 3.89) | | | Gender | | | 92.0 | 0.447 | | 84.5 | 0.295 | Male | 28 | 7.93 (6.80, 14.00) | | | 2.77 (1.33, 4.36) | | | Female | 8 | 7.77 (4.22, 13.12) | | | 1.20 (1.01, 4.79) | | | Lymph node metastasis | | | 22.0 | 0.035 | | 37.5 | 0.182 | Negative | 32 | 8.41 (6.83, 14.33) | | | 2.76 (1.19, 4.46) | | | Positive | 4 | 4.04 (2.293, 9.41) | | | 1.38 (0.94, 2.56) | | | Depth of invasion | | | 48.0 | 0.421 | | 62.5 | 0.940 | T1-T2 | 4 | 5.72 (4.74, 6.77) | | | 1.47 (0.67, 2.70) | | | T3-T4 | 32 | 8.67 (6.83, 14.33) | | | 2.76 (1.19, 4.46) | | | Degree of differentiation | | | 119.0 | 0.525 | | 124.0 | 0.643 | Poor | 25 | 8.63 (6.48, 14.01) | | | 2.81 (1.10, 4.96) | | | Well | 11 | 7.35 (5.26, 11.03) | | | 2.13 (1.06, 2.97) | | | Tumor size | | | 107.0 | 0.127 | | 104.0 | 0.105 | ≤5 cm | 14 | 6.84 (4.45, 15.00) | | | 1.82 (1.02, 3.22) | | | >5 cm | 22 | 8.87 (7.30, 12.63) | | | 3.05 (1.32, 6.48) | | | TNM stage | | | 53.0 | 0.053 | | 71.5 | 0.230 | I–II | 7 | 5.26 (3.53, 11.03) | | | 1.73 (0.91, 2.97) | | | III–IV | 29 | 8.63 (6.91, 14.01) | | | 2.70 (1.22, 4.96) | | | CEA (0-5 ng/ml) | | | 84.0 | 0.287 | | 90.0 | 0.402 | ≤5 | 28 | 8.67 (6.79, 14.33) | | | 2.91 (1.09, 5.21) | | | >5 | 8 | 6.91 (4.63, 11.33) | | | 2.02 (1.21, 2.78) | | |
|
|